Solriamfetol treatment of excessive daytime sleepiness in Parkinson's disease: Results from a phase 2 proof-of-concept trial

Authors
Category Primary study
JournalSleep
Year 2019
This article has no abstract
Epistemonikos ID: dfcd55fba2bff452898754f1ae5ba2d6975426d9
First added on: Feb 10, 2025